Comprehensive Guide to Medical Corporation Fund Refunds: Timing and Tax Accounting in M&A and Succession

📖 Approx. 12 minPublished 09.10.2026

In the management of a medical corporation, “contributed funds” (kikin) serve as a critical element; however, their refund involves unique statutory rules and complex tax accounting. When considering healthcare M&A or business succession in particular, how these funds are handled can substantially impact the corporation’s financial standing and post-succession operations. This article provides a comprehensive guide for directors and board chairs of medical corporations with contributed funds, as well as prospective buyers and successors, detailing the legal requirements, procedural steps, financial and tax implications, and key focal points of fund refunds during M&A and business succession.

What Are “Contributed Funds” in a Medical Corporation? Differences from Equity Interests

Medical corporations in Japan are broadly classified into “medical corporations with equity interests” (ownership shares) and “medical corporations without equity interests” based on their structure of establishment. Following the revision of the Medical Care Act in 2007, newly established medical corporations can only be formed as medical corporations without equity interests (either as medical corporations with contributed funds or foundation-based medical corporations). Among these, the most widely adopted structure is the “medical corporation with contributed funds” (kikin-kyoshutsu-gata iryo hojin).

A contributed fund refers to money or other assets contributed by members (shain), directors, or others at the time of incorporation or business expansion to establish a stable operating foundation for the medical corporation. Although recorded as part of the corporation’s assets, its nature differs from common corporate capital stock and carries characteristics closer to debt. By setting forth provisions in the articles of incorporation, the corporation incurs an obligation to refund the contributed funds to contributors within the scope permitted by the corporation’s asset situation.

In contrast, an equity interest in a “medical corporation with equity interests” represents a co-ownership share in the corporation’s assets, allowing for refunds upon withdrawal or dissolution proportional to the evaluated net asset value. Because this valuation is tied directly to the corporation’s net assets, these equity interests historically tended to escalate dramatically in value, creating major succession challenges.

In a medical corporation with contributed funds, the contributed capital is treated as a liability of the corporation. When the corporation is dissolved or when events specified in the articles of incorporation occur, the funds are refunded to the contributors. However, the refund amount is capped at the principal amount originally contributed, and the distribution of surplus earnings is strictly prohibited. This is the fundamental difference between equity interests and contributed funds, and it is a key reason why medical corporations with contributed funds are regarded as healthcare institutions with high public-interest status.

Item	Medical Corporation with Equity Interests	Medical Corporation with Contributed Funds
Establishment Period	On or before March 31, 2007	On or after April 1, 2007 (or transitioned from an existing corporation)
Nature of Contributed Capital	Net assets of the corporation (equity interests)	Liability of the corporation (contributed fund)
Valuation upon Return	Valuation based on net asset value	Principally capped at the original contribution amount
Distribution of Surplus	Permitted (proportional to equity interest)	Prohibited
Valuation at Succession	Prone to sharp increases	Principally equal to the original contribution amount
Public-Interest Nature	Regarded as low	Regarded as high

Legal Requirements and Step-by-Step Procedure for Fund Refunds

The refund of contributed funds must be executed in accordance with the requirements stipulated in the medical corporation’s articles of incorporation. Under Article 44-2, Paragraph 4 of the Medical Care Act, “matters concerning the refund of contributed funds shall be prescribed in the articles of incorporation,” making these provisions the legal basis for any refund. Generally, fund refunds are permitted only at the end of the fiscal year when the corporation maintains an adequate financial surplus.

The specific refund procedure often mutatis mutandis applies the provisions governing capital reductions under the Companies Act and generally follows these steps. However, because administrative interpretations and practices may vary by prefecture, prior consultation with the supervisory authority is essential.

1. Review and Amendment of the Articles of Incorporation: Confirm whether provisions governing fund refunds are explicitly stated in the articles of incorporation. If the provisions are insufficient or refund conditions need modification, amend the articles through a special resolution of the General Meeting of Members.
2. Approval at the General Meeting of Members: Because a fund refund represents a material financial transaction, it fundamentally requires approval via a special resolution of the General Meeting of Members. The refund amount, timing, recipients, and terms must be formally resolved.
3. Creditor Protection Procedures: Applying the capital reduction procedures of the Companies Act by analogy, creditor protection procedures may be required. This is because a fund refund reduces corporate assets, potentially prejudicing creditor interests. An official gazette (Kanpo) notice and individual notifications to known creditors must be conducted, providing an objection period of usually not less than one month. If no objections are raised, the process moves forward; if objections arise, the corporation must satisfy the claims or provide adequate collateral.
4. Execution of Refund: Once creditor protection procedures are successfully concluded, the fund refund is executed in accordance with the resolution. Refunds are, in principle, paid in cash.
5. Registration of Changes (if applicable): If matters concerning the fund are subject to corporate registry filings, a registration of modification may be required following the refund.
6. Notification to Supervisory Authorities: Because a fund refund is a material change for a medical corporation, a post-refund notification must be submitted to the competent prefectural governor (or the Ministry of Health, Labour and Welfare).

The complexity of these steps varies depending on the corporation’s financial standing, charter provisions, and regulatory guidance. Creditor protection procedures, in particular, demand specialized legal knowledge, making close collaboration with attorneys, judicial scriveners, and certified tax accountants vital.

Financial Impact of Fund Refunds on Medical Corporations

Refunding contributed funds directly and significantly impacts the financial structure of a medical corporation. Because the fund is recorded as a liability, executing a refund reduces corporate assets by that amount while simultaneously decreasing liabilities. However, this is far more than a mere shift of numbers on the balance sheet.

First, the impact on cash flow is unavoidable. Refunding funds causes a direct outflow of cash and cash equivalents. If a substantial amount is refunded in a lump sum, the corporation faces the risk of a shortfall in working capital, future capital expenditures, renovation budgets, or personnel recruitment funds. In situations requiring heavy capital investments—such as restructuring operations ahead of medical reimbursement fee revisions or transitioning bed functions under the Regional Medical Care Vision—the implications on liquidity must be carefully modeled.

Second is the impact on the equity ratio. Although the fund is listed as a liability, its repayment alters the relative debt-to-equity ratio against the corporation’s net assets. When seeking bank loans, the equity ratio is a critical credit underwriting benchmark. If financial institutions determine that the balance sheet has weakened following a fund refund, procuring new loans may become difficult, or existing credit terms could be adversely affected.

Third, indirect effects on facility standards (shisetsu kijun) for medical fee billing must be considered. Many facility standards require solid financial backing to maintain mandatory staffing ratios and specialized medical equipment. If the financial foundation is undermined by a fund refund, required investments may stall, creating risks of decreased medical reimbursement billing tiers or forfeiture of facility accreditations. For instance, acquiring high-performance diagnostic devices or retaining specialized physicians and nurses demands robust capital strength.

Furthermore, it influences business continuity and long-term growth strategies. Contributed funds frequently serve as a vital source of financing during initial setup and expansion phases; refunding them may restrict future operational flexibility. In an M&A or succession scenario, buyers conduct rigorous due diligence to scrutinize the corporation’s capacity to refund funds and assess post-refund financial sustainability.

Tax Accounting and Key Points for Fund Refunds

Fund refunds trigger tax considerations for both the contributor and the medical corporation. A precise understanding of their legal and fiscal nature is essential to ensure proper accounting treatment.

Taxation for the Fund Contributor

By their legal nature, contributed funds differ from paid-in capital and are treated as debt-like obligations from the perspective of the contributor. Therefore, as a general rule, when a medical corporation refunds the fund, the refunded amount is tax-free for the contributor. This is because the contributor is merely receiving back previously contributed capital, and no new income or gain is deemed to have been generated.

However, the following exceptional scenarios warrant careful attention:

• When Interest Is Paid: If the articles of incorporation specify that interest accrues on the fund and interest is actually paid, that interest is subject to taxation as interest income for the contributor.
• When Deemed a Substantive Benefit/Distribution of Profit: If the refund amount significantly exceeds the original contribution amount, or if an unnaturally inflated refund is executed, tax authorities may view it as a disguised economic benefit from the corporation to an individual, potentially subjecting it to gift tax or income tax. Tax authorities consistently prioritize economic substance over form.
• Refunds Accompanying Member Changes: When funds are refunded alongside changes in leadership, such as the resignation of a chairman, careful documentation is required to confirm that the timing and valuation are commercially justified to avoid tax disputes.

Taxation for the Medical Corporation

For the medical corporation, refunding a fund is a balance-sheet transaction that reduces debt and does not affect the profit and loss statement (P&L). Consequently, the refund itself has no impact on taxable corporate income. In other words, refund payments cannot be deducted as corporate expenses (loss).

Regarding Japanese consumption tax, the contribution and refund of funds are non-reciprocal financial transactions without consideration, making them outside the scope of consumption tax. However, any administrative fees or third-party handling costs incurred during the process may be taxable.

The treatment of enterprise tax (jigyo-zei) is also relevant. Enterprise tax for medical corporations is calculated based on taxable corporate income. Since fund refunds do not alter corporate taxable income, they do not directly change enterprise tax amounts. Nevertheless, if the repayment changes the corporate financial structure and affects future earnings, it could indirectly influence future enterprise tax liabilities.

During tax audits, examiners frequently scrutinize whether fund contributions and refunds were executed properly, whether they conformed to the articles of incorporation, and whether any improper profit transfers occurred. In M&A and business succession contexts, the economic rationale and commercial background of the refund will be tested; maintaining complete supporting documentation, including minutes of the General Meeting of Members and contractual agreements, is critical.

Focal Points in M&A and Business Succession Concerning Fund Refunds

In healthcare M&A and succession, fund refunds represent a major negotiation point. Because they affect the acquirer, seller, and future management in diverse ways, exhaustive preliminary analysis is required.

The Acquirer’s (Successor’s) Perspective

For the buyer, acquiring a medical corporation with contributed funds requires a distinct methodology compared to acquiring one with equity interests. With equity-holding corporations, the purchase price is primarily tied to the valuation of equity interests (linked to net asset value). In a fund-based corporation, however, the fund refund obligation exists on the books as corporate debt.

Because the buyer inherits this refund obligation upon succession, the following items must be thoroughly vetted during legal and financial due diligence:

• Provisions in the Articles of Incorporation: Detailed clauses regarding refund conditions, refund caps, repayment terms, and interest accrual.
• Total Fund Balance and Identity of Contributors: The total scale of the fund and who holds the refund claim. Member or chairman resignations frequently trigger refund demands.
• Financial Health and Cash Position: Whether the corporation holds sufficient cash reserves to absorb the refund while maintaining operational stability.
• Alignment with the M&A Transaction Structure: Clear contractual terms detailing how the fund will be handled (e.g., refunded post-closing, substituted by a new contributor, or waived).

Because fund refunds can severely strain post-closing working capital, they must be factored directly into enterprise valuation, purchase price adjustments, and post-merger integration (PMI) financial planning.

The Seller’s (Current Management’s) Perspective

For the seller, the timing and mechanism for recovering their contributed funds is of paramount interest. Unlike sellers of corporations with equity interests who can monetize accumulated retained earnings via share purchase prices, sellers of fund-based corporations cannot extract large capital gains. Recovering their contributed principal serves as their primary legitimate liquidity event from the legal entity.

• Negotiating the Refund Schedule: Defining clear milestones within the succession agreement regarding whether the refund will be executed in a lump sum or installments, and within what timeframe post-closing.
• Assessing Tax Implications: Ensuring the refund adheres to principal repayments without attracting recharacterization as taxable income or gifts.
• Structure Selection: Coordinating fund treatment with the overarching deal structure, whether structured as a change of corporate members, business transfer, or merger.

Furthermore, correlation with the Regional Medical Care Vision should be considered. Due to their high public-interest character, medical corporations with contributed funds can more seamlessly integrate into Regional Medical Care Coordination Promotion Corporations (Chiiki Iryo Renkei Suishin Hojin). Structuring the fund resolution with an eye toward future regional integration can preserve corporate goodwill.

Finally, indirect impacts on permits and licenses must not be overlooked. If a fund refund severely impairs the corporation’s capital adequacy, it could invite regulatory inquiries from the prefectural government or hinder future licensing applications (such as expanding bed capacities or adding specialty clinical departments).

Key Factors to Determine the Optimal Timing for Fund Refunds

Executing a fund refund is a strategic managerial decision. Determining the appropriate timing requires a multidimensional evaluation, especially when preparing for M&A or ownership transition.

The ultimate consideration is the corporation’s financial strength and forward-looking business plan. Destabilizing clinical operations for the sake of a fund refund must be strictly avoided. Factors unique to the healthcare industry—such as reimbursement tariff adjustments and local healthcare restructuring—demand conservative cash planning. Thoroughly assess whether internal reserves are adequate, whether projected cash flows are robust, and whether recruitment and capex budgets will remain fully protected.

Furthermore, transitions in corporate membership provide a natural juncture to execute refunds. As outgoing board chairs and members depart, resolving their contributed funds is standard practice. Aligning the interests of both incoming and outgoing members through documented consensus and manageable repayment schedules ensures a seamless transition without creating liquidity bottlenecks.

Because refunding contributed funds entails technical legal and accounting processes—including charter revisions and statutory creditor notifications—engaging specialized professionals is indispensable. Collaborating with attorneys, tax accountants, CPAs, and healthcare M&A advisors ensures compliant documentation, mitigation of tax risks, and effective negotiation support throughout the transaction.

The refund of medical corporation funds involves multifaceted statutory and strategic complexities. To achieve a successful M&A or succession outcome, early consultation with dedicated specialists is essential to formulate a strategy tailored to your corporation’s exact circumstances. At M&A Medical, our seasoned advisors specialize exclusively in the healthcare sector, offering comprehensive advisory services for fund refunds, medical practice sales, and succession planning. Contact us today for a confidential, complimentary consultation.

---

Consult M&A Medical for Healthcare Succession

M&A Medical is a dedicated advisory firm specializing in mergers, acquisitions, and business succession for healthcare institutions. As a certified M&A support agency registered with the Small and Medium Enterprise Agency, we support owners facing succession challenges—from practice transfers to strategic acquisitions—on a success-fee basis.

• Free initial consultation and preliminary valuation
• Zero retainer or monthly fees (success-fee only structure)
• Strict confidentiality guaranteed under NDA
• Full coverage across all 47 prefectures and all medical specialties

Whether you wish to understand your practice’s market valuation, have no designated successor, or are exploring integration into a medical group, we encourage you to contact us early in your planning phase.

Request a Free Consultation